4 completed, 3 active not recruiting, 2 enrolling by invitation, 1 no longer available. 3 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 3 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow concizumab: new trials by email Literature Review of concizumab trials Research Report on concizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo Concizumab - Haemophilia A, Haemophilia B | Enrolling by invitation | Novo Nordisk A/S | 30 | 2025-05-02 | 2026-06-15 | |
| Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors Concizumab - Haemophilia A, Haemophilia B | Enrolling by invitation | Novo Nordisk A/S | 23 | 2024-08-08 | 2026-06-15 | |
| Targeting TFPI With Concizumab to Improve Haemostasis in Glanzmann Thrombasthenia Patients: an in Vitro Study Clot formation in whole blood under flow in a microfluidic flow chamber coated with tissue factor and collagen, : PRP viscoelastic changes under clot formation measured by thromboelastometry using RoTEM, Thrombin Generation Assay (TGA) in PRP using TF trigger - Glanzmann Thrombasthenia | Not applicable | Completed | University Hospital, Bordeaux | 20 | 2023-04-06 | 2026-05-26 |
| A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors Concizumab - Haemophilia A and B With and Without Inhibitors | Phase 3 | Active not recruiting | Novo Nordisk A/S | 153 | 2022-03-24 | 2026-09-18 |
| Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors Concizumab - Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors | Phase 3 | Active not recruiting | Novo Nordisk A/S | 156 | 2019-11-13 | 2026-09-16 |
| Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors Concizumab - Haemophilia A With Inhibitors, Haemophilia B With Inhibitors | Phase 3 | Active not recruiting | Novo Nordisk A/S | 134 | 2019-10-21 | 2026-09-09 |
| A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors Concizumab, Turoctocog alfa - Haemostasis, Haemophilia A | Phase 2 | Completed | Novo Nordisk A/S | 36 | 2017-08-16 | 2021-11-16 |
| A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B Patients With Inhibitors Concizumab, Eptacog alfa - Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Phase 2 | Completed | Novo Nordisk A/S | 26 | 2017-08-10 | 2021-10-22 |
| Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects Concizumab, placebo - Congenital Bleeding Disorder, Haemophilia A | Phase 1 | Completed | Novo Nordisk A/S | 24 | 2015-09-10 | 2017-07-21 |
| Compassionate Use of Concizumab if You Have Haemophilia Concizumab - Congenital Haemophilia | No longer available | Novo Nordisk A/S | 2026-10-28 |
Hemophilia A (5) · Hemophilia B (2) · Thrombasthenia (1)
Novo Nordisk A/S (9) · University Hospital, Bordeaux (1)
Japan (7) · United States (7) · France (6) · Spain (6) · Sweden (6) · United Kingdom (6) · Italy (5) · Malaysia (5) · Thailand (5) · Turkey (Türkiye) (5) · Ukraine (5) · Bulgaria (4) · Canada (4) · Croatia (4) · Poland (4)
PMID 31444162, PMID 35290453, PMID 37646676, PMID 38880178, PMID 39099801, PMID 39521008, PMID 40166710, PMID 41499759, PMID 42341325
2016 (2), 2018 (2), 2014 (1)